Analystreport

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is now covered by analysts at Aegis. They set a "buy" rating on the stock.

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors